Large, two-year data set analyzed by Mass General Hospital demonstrates that nearly 60% of users who completed the Mahana IBS program in the real world setting reported clinically meaningful reduction in severity of IBS symptoms.SAN FRANCISCO--(BUSINESS
Allogeneic Cell Therapy for the Treatment of Corneal Edema Secondary to Corneal Endothelial DysfunctionSEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing rege
Two posters highlight ability of the TissueCypher test to identify higher- and lower-risk subsets of patients with Barrett’s esophagus than indicated by their clinicopathologic factors to guide risk-aligned patient careFRIENDSWOOD, Texas--(BUSINESS WIR
Once-a-day oral dosing with omilancor induced clinical remission in 30.4% of active Ulcerative Colitis (UC) patients versus 3.7% in the placebo group (Δ=26.7%, P = 0.01) Once-a-day oral dosing with omilancor in active Crohn’s disease (CD) patients sho
TORONTO--(BUSINESS WIRE)--$cann #cann--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQB: HERTF) (“Heritage” or the “Company”), is pleased to announce that recreational product sales in the state of New York has officially commenced. Manufacturi
VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), an AI-driven biotherapeutic research and technology company wishes to provide an update on its overall growth strategy, particular
This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17, 2023. - Combined portfolios create the industry’s la
On October 23rd, at the EGM of shareholders, the merger agreement between Celltrion, Inc. & Celltrion Healthcare Co., Ltd. was approved Celltrion Group’s board of directors resolved to retire and acquire treasury stocks in a bid to maximize share
WINNIPEG, Manitoba--(BUSINESS WIRE)--Bioscience Association Manitoba (BAM) is thrilled to extend a warm and enthusiastic welcome to the newly appointed ministers who will play a pivotal role in advancing the bioeconomy in our province. “I am honored to
TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") (TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, announced today that it will release its third quarter 2023 financial
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.